02.24.25 -- STREAM Edition: Advancing Drug Development: Innovations In Biologics, Lyophilization, And Manufacturing

Using a comprehensive approach to component selection mitigates risks to fill-finish and lyo processing. Explore key considerations for selecting lyophilization stoppers suitable for intended use.

We offer comprehensive support for complex biologic drug candidates and bioconjugates, encompassing everything from discovery through developability assessment, lead selection, and optimization.

Discover how microencapsulation by coacervation can transform your formulations, ensuring smooth mouthfeel, effective taste masking, and customized release profiles.

If you're looking for a dedicated partner who prioritizes trust, transparent communication, and delivering results that exceed expectations, let's work together to drive your project's success and create lasting impact.

Translating novel drug discoveries into clinical trials remains a complex endeavor. Learn how a CDMO with cutting-edge technologies can facilitate a smooth path from discovery to FIH studies.

Implement analysis using sedimentation velocity analytical ultracentrifugation to characterize AAV size distributions and multiple detection wavelengths to identify various fill states in AAV preparation.

FUJIFILM Diosynth Biotechnologies is building the largest end-to-end CDMO facility for biologics in North America.

Watch as bioanalytical experts Shane Karnik, MS, and Matt Hartle, Ph.D., explore why many sponsors are reevaluating the use of LBA for large molecule protein analysis in favor of LC-MS.

You can count on our extensive scientific and manufacturing expertise, stringent quality standards, and highly responsive customer service to ensure timely delivery of your life-changing products.

Watch to uncover the key benefits of outsourcing your OSD production and explore real-world examples and best practices to help you streamline your processes and enhance your operational agility.